Sledovat
Vicente Vicente Garcia
Vicente Vicente Garcia
Profesor Universidad de Murcia
E-mailová adresa ověřena na: carm.es - Domovská stránka
Název
Citace
Citace
Rok
Platelet receptors and signaling in the dynamics of thrombus formation
J Rivera, ML Lozano, L Navarro-Núñez, V Vicente
haematologica 94 (5), 700, 2009
5732009
Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells
DA Cheresh, SA Berliner, V Vicente, ZM Ruggeri
Cell 58 (5), 945-953, 1989
4591989
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
A Alvarez-Larrán, A Pereira, F Cervantes, E Arellano-Rodrigo, ...
Blood, The Journal of the American Society of Hematology 119 (6), 1363-1369, 2012
3332012
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
A Alvarez-Larrán, F Cervantes, A Pereira, E Arellano-Rodrigo, ...
Blood, The Journal of the American Society of Hematology 116 (8), 1205-1210, 2010
3002010
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
E García-Martínez, GL Gil, AC Benito, E González-Billalabeitia, ...
Breast cancer research 16, 1-17, 2014
2952014
Polymorphisms of Platelet Membrane Glycoprotein Ib Associated With Arterial Thrombotic Disease
R Gonzalez-Conejero, ML Lozano, J Rivera, J Corral, JA Iniesta, ...
Blood, The Journal of the American Society of Hematology 92 (8), 2771-2776, 1998
2911998
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a “real-world” population with atrial fibrillation receiving anticoagulant therapy
V Roldán, F Marín, H Fernández, S Manzano-Fernandez, P Gallego, ...
Chest 143 (1), 179-184, 2013
2892013
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time
PM Mannucci, V Vicente, L Vianello, M Cattaneo, I Alberca, MP Coccato, ...
2721986
The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial …
V Roldán, F Marín, S Manzano-Fernández, P Gallego, JA Vílchez, ...
Journal of the American College of Cardiology 62 (23), 2199-2204, 2013
2542013
Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor
JA Guerrero, ML Lozano, J Castillo, O Benavente‐Garcia, V Vicente, ...
Journal of Thrombosis and Haemostasis 3 (2), 369-376, 2005
2522005
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm
S Gretarsdottir, AF Baas, G Thorleifsson, H Holm, M Den Heijer, ...
Nature genetics 42 (8), 692-697, 2010
2412010
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?
R Gonzalez-Conejero, J Rivera, J Corral, C Acuna, JA Guerrero, ...
Stroke 36 (2), 276-280, 2005
2392005
Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
V Vicente, RA Houghten, ZM Ruggeri
Journal of Biological Chemistry 265 (1), 274-280, 1990
2311990
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
P Gallego, V Roldan, F Marín, M Romera, M Valdés, V Vicente, GYH Lip
Thrombosis and haemostasis 110 (12), 1189-1198, 2013
2202013
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation
P Gallego, V Roldán, JM Torregrosa, J Gálvez, M Valdés, V Vicente, ...
Circulation: Arrhythmia and Electrophysiology 5 (2), 312-318, 2012
1952012
Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis
MD Tabernero, JF Tomas, I Alberca, A Orfao, AL Borrasca, V Vicente
American journal of hematology 36 (4), 249-254, 1991
1931991
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients
V Roldán, F Marín, B Muiña, JM Torregrosa, D Hernández-Romero, ...
Journal of the American College of Cardiology 57 (25), 2496-2504, 2011
1722011
SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation
P Gallego, V Roldán, F Marin, J Gálvez, M Valdés, V Vicente, GYH Lip
The American journal of medicine 127 (11), 1083-1088, 2014
1712014
The FXIII Val34Leu polymorphism in venous and arterial thromboembolism
J Corral, R González-Conejero, JA Iniesta, J Rivera, C Martínez, ...
Haematologica 85 (3), 293-297, 2000
1572000
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis
J Corral, D Hernandez-Espinosa, JM Soria, R Gonzalez-Conejero, ...
Blood 109 (10), 4258-4263, 2007
1532007
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20